Linear Clinical Research Current Trials Menu

Give your therapy a head start

Take it to market sooner

Our world-class early-phase and late-phase clinical trial and research capabilities will give you the clinical data and insights you need to realise your therapy’s medical and commercial potential sooner.

Why choose Linear?

Be part of something special.
Volunteer with us.

As a paid clinical trial volunteer, you’re playing a key role in pivotal clinical and medical research that will change and save lives.

Learn more

Join our extended research team. Collaborate with us.

We’re at the heart of a global network of clinical researchers and medical innovators, and you can be part of it.

Find out more

Why Australia and Perth?

Did you know, Australian (TGA) clinical trial start-ups are typically 4-6 months faster than US (FDA) trials? Better still, they’re much cheaper – often a third of the cost and exceptional quality. And with our concept-to-commercialisation capabilities, we can compress those timeframes and costs even further.

  • No IND required
  • Fast-tracked approvals
  • Generous tax breaks
  • Population: 2.2m
  • Asian time zone
  • Excellent health system
  • Access to patient databases
  • Data accepted by FDA, EMA, CFDA & PDMA
  • Diverse population

More about Australia & Perth


Why Linear?

From actively expediting clinical trial start-ups and recruitment, through to providing the data, insights and services you need to successfully go to market, our world-class end-to-end clinical research capabilities will get you there faster.

More about our advantage

  • 10,000+ volunteers in our database
  • Close links with state health department
  • Vast medical and collaborator network
  • State-of-the-art 32-bed facility (expanding up to 40)
  • One of Australia’s largest health precincts
  • On-site CRA monitoring rooms and lab
  • On-site pharmacy, medical and QA resources
  • Experienced in complex, first-in-human studies
    (over 145 trials completed)
  • Live quality control

“We’ll work with you to assess and realise the full medical and commercial value of your work, sharing our insights and network of partners to drive your therapy or product to fruition, swiftly and safely.”

Dr. Michael Winlo MBBS(Hons), MBA Chief Executive Officer, Linear

What our clients say

The phase one study we conducted with Linear was intricate, intensive and novel. Despite these challenges, the Linear team was impressive in its professionalism and commitment to delivering results and ensuring the study was a success.

Craig Cook Midatech, Oxfordshire, UK

Linear not only paid great attention to our project, but also worked hard to establish and maintain great working relationships … We look forward to working with Linear on more projects in the near future.

Xu Ning Zai Labs, Shanghai, China

With a very tight timeline for the study, we approached several CROs, and found that Linear was most on board with us from the very beginning. We were very impressed with the problem-solving approach...

Claire Kaufman Paradigm, Sydney, Australia

Linear was an outstanding partner for our phase one programs – always professional and willing to go the extra mile.

Steve Gourlay CMO Principia, San Francisco, USA